Background Geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD), leads to legal blindness in approximately 16% of affected individuals within 6 years. Numerous trials have evaluated interventions to slow GA progression, and many studies are ongoing. However, the comparative benefits and h...
M. Ghadimi, Housne Begum, Dena Zeraatkar et al.· PLoS ONE· 0 citations
Current evidence on the definition, epidemiology, risk factors, imaging features, and functional consequences of MA in nAMD are summarized and standardized definitions, multimodal imaging, and predictive models are guided to guide personalized management and develop therapies targeting atrophy.
Xue-Nan Zhuang, Chiara Olivieri, G. Neri et al.· Survey of ophthalmology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.